December 5, 2024 – Canine Brain Tumor Clinical Results and more news…

Published: December 5, 2024

December 5, 2024

Canine Brain Tumors: First Histotripsy Clinical Trial Results Published

A clinical trial in pet dogs demonstrated the safety and feasibility of treating brain tumors with histotripsy.
Co-funded by the Foundation and the American Kennel Club’s Canine Health Foundation, this study supports the development of transcranial histotripsy systems for both human and canine patients.

From Alzheimer’s to ALS: The Latest in Brain Immunology

In this podcast, John Lukens, PhD, shares his research on the connection between the immune system and the brain in combating neurological disorders.
Learn how focused ultrasound could enhance immunotherapy and provide new treatments for conditions like Alzheimer's, ALS, and brain tumors.

Listen to the Episode

Neck Dystonia: Focused Ultrasound Clinical Trial Results

Data from a 10-patient pilot clinical trial using focused ultrasound to treat cervical dystonia were recently published.
Cervical dystonia is a rare neurological disorder that causes uncontrollable neck muscle contractions.

Focused Ultrasound Featured in NIH’s Clinical Neuroscience Grand Rounds

Focused ultrasound was the topic of the November 12 Clinical Neuroscience Grand Rounds hosted by the National Institutes of Health (NIH).
NIH Clinical Center Senior Scientist, Scott Burks, PhD, and Suzanne LeBlang, MD, the Foundation’s director of clinical relationships presented the latest research.

UK Event Raises Awareness for Focused Ultrasound in Pediatrics

Three leading experts discussed focused ultrasound research for critically ill infants and children.
The event was hosted by the UK Focused Ultrasound Foundation, an organization that aims to advance the technology in the region.

First Patients Enrolled in Histotripsy Liver Tumor Master Study

HistoSonics recently announced the launch of its prospective master protocol study, called BOOMBOX.
The study will collect data from thousands of patients and analyze histotripsy’s potential as a monotherapy, combination therapy, and primer for additional treatments.

Read the Press Release

New Insightec Device Earns FDA Approval and CE Marking

Insightec’s new Exablate Prime focused ultrasound device has been cleared in the US and Europe for use with certain Philips MR systems.
Launched in January 2024, Exablate Prime enables incisionless neurosurgery as an outpatient procedure for movement disorders.

Read the Press Release

Last Chance: Apply for the Lockhart Postdoctoral Fellowship in Focused Ultrasound and Immuno-Oncology

This one-year fellowship pairs an early-career scientist with a leading laboratory to foster focused ultrasound immuno-oncology research.
The recipient will receive a $75,000 stipend, and applications are due December 16.

Learn More and Apply

Focused Ultrasound Featured at Leading 2024 Conferences

Read the 2024 Meeting Reports

New Book Highlights the Power of Focused Ultrasound

In Beyond Imaging, author Victor Frenkel, PhD, provides an overview of the history and current state of therapeutic ultrasound research.
The book's description notes that it "is meant for anyone who loves cutting edge technology, especially pertaining to medical treatments.”

Learn More

Forwarded this email by a friend? Sign up to receive these emails here.

And Don't Miss

UVA Researcher Pens Acoustics Today Paper | How Sound Waves Could Revolutionize Cancer (Immuno)therapy

American Society of Gene and Cell Therapy Quick Take | Focused Ultrasound in Cell and Gene Therapies

New Venture Capital Fund for Women's Cardiovascular and Brain Health Innovation | See the Go Red For Women Fund

See Recent News

Events

December 10-12, 2024 British Medical Ultrasound Society (BMUS), Coventry, United Kingdom

January 13-16, 2025 JP Morgan Healthcare Week, San Francisco, California, USA

January 16-17, 2025 30th European Symposium on Ultrasound Contrast Imaging, Rotterdam, The Netherlands

See All Upcoming Events

Do you have news for our newsletter? Tell us about it!

“One strategy that has shown to be quite effective and exciting is using focused ultrasound to target the opening of the blood-brain barrier to get those beneficial antibodies to where they need to be to have their most beneficial effect.”

‒ John Lukens, PhD

December 5, 2024 – Canine Brain Tumor Clinical Results and more news…

Contact

Terms of Use